chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small red spots on skin like capillary breaks (petechiae and small purpura); Small red spots on skin like capillary breaks (petechiae and small purpura); This is a spontaneous report from a contactable healthcare professional (patient) received via database. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on 25Feb2021 at 09:45 AM (Batch/Lot number was not reported) (at the age of 39 years old) as dose number unknown, single for COVID-19 immunisation in a hospital. The patient's medical history was not reported. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has no known allergies. The patient was not pregnant at the time of vaccination. The patient was taking unspecified concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced painless small red spots on skin like capillary breaks (petechiae and small purpura) on 26Feb2021 at 08:00 AM. It was unknown if the patient received treatment for the events. The outcome of events was unknown.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Her son has a tendency to have transient synovitis 4-7 weeks following a cold or a virus.; Her son has a tendency to have transient synovitis 4-7 weeks following a cold or a virus.; Her son has a tendency to have transient synovitis 4-7 weeks following a cold or a virus.; This is a spontaneous report from a contactable consumer (Mother). A male patient of an unspecified age received pneumococcal 13-val conjugate vaccine (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced a tendency to have transient synovitis 4-7 weeks following a cold or a virus on unspecified date. The mother reported her son has never had it after a vaccine. They have been in quarantine and have not been exposed to any sickness. Her son had what looked like a transient episode this week. It has went away.  The mother was asking if there is any report of joint inflammation with pneumococcal 13-val conjugate vaccine (dipht crm197 protein). The events were non serious. The outcome of the event synovitis was recovered on unspecified date. The outcome of the events cold and viral infection was unknown.  No follow-up attempts are Needed; information about lot/batch number cannot be obtained.
she was pregnant when the vaccine was administered.   she had a negative pregnancy in our office on 3/3/20, we administered the vaccine (varicella).  she had a positive home pregnancy test on 3/26/20.  ultrasound on 4/15/20 dates the pregnancy to be 8 weeks.
These symptoms started the evening the vaccine was administered and lasted for a few days: glandular swelling, red, itching welts on neck, face, wrist and chest, lip tingling, facial flushing.  Flu-like symptoms: fever, malaise, sore throat started the day after vaccine administered and lasted until 12/14 Patient is feeling better now and did not seek medical treatment for these symptoms.
injection site redness; injection site swelling; A report was received from a consumer concerning a female patient of an unknown age, who received Moderna's mRNA-1273 and developed redness and swelling around the injection site.   The patient's medical history and relevant concomitant medications were not reported.   On 28 Dec 2020, approximately one week prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 intramuscularly in the for prophylaxis of COVID-19 infection.   The patient experienced redness and swelling around the injection site on an unknown date about a week after receiving vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events redness and swelling were not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I was fine for 24 hours after receiving it then experienced soreness, fatigue, body aches, chills
sore arm at site of shot, felt tired, had muscle pain, a headache, shivering, fever, stomach pain,  and nausea; woke during the night.  Stayed home from work; symptoms are persistent throughout the day (05/10/2023)
2/24/22  66 yr/o female with hx DM, HTN, HLD, CKD, hypothyroidism, morbid obesity, bipolar disorder, and anxiety who presents with a headache that awoke her from sleep 3 or 4 hours ago, nausea, generalized weakness with heaviness and tingling in both of her arms.  She denies any vomiting.  She is unaware of any fever but states she felt very tired last night and went to bed early at 8 PM.  She was noted at triage to have a temperature of 100.2.  She denies any chest or abdominal pain. REVIEW OF SYSTEMS   Constitutional: Negative for fever.  Negative for chills.  HENT: Negative for sore throat. Eyes: Negative for pain Respiratory: Negative for cough. Negative for shortness of breath.  Cardiovascular: Negative for chest pain. Negative for palpitations.  Gastrointestinal: Positive for nausea. Negative for vomiting. Negative for abdominal pain.  Negative for diarrhea.  Genitourinary: Negative for difficulty urinating.  Skin:  Negative for rash.  Neurological: Positive for gen weakness.  Positive for headache.  Psychiatric/Behavioral: Negative for depression 2/25/22   presented to ER with reports of HA and body aches.  She also noted chest pain.  Please note she frequents are ER with a variety of somatic complaints which are often neurologic in description.  Recent evaluations have been reassuring.  She was noted to have low grade temp and admitted to cough in ER.  I was concerned for COVID on admission.  ER requested admission for "hypoxia".   I turned off O2 when I saw patient in ER and her sats have never been low.  She has acrylic nails on which may have been reason for her low O2 sat readings.  Her COVID test returned positive as expected.  Her daughter has been having similar symptoms and I told her in ER she should be tested as she likely has COVID in fact she probably gave COVID to patient.  I am told she was advised by nursing staff not to visit patient but she came anyway.   Patient has had no hypoxia nor increased WOB.  CTA negative for PE, only minimal GGO's which would by typical for COVID.   Given patient is not hypoxic and has no increased WOB, I think she can go home.  I advised daughter that if patient becomes SOA she should be evaluated.  No role for steroids at this juncture   I expressed my concerns to infection control that family members with COVID should not be allowed to visit hospital.  Discharge exam notable for: awake, chronically ill appearing, appears dazed as seen during prior encounters
Patient is a 61 y.o. male patient of, DO with history of diabetes mellitus that presented to Hospital with cough, nausea, shortness of breath. Patient found to have COVID pneumonia and initially required 6 L O2 via nasal cannula on admission.  Patient was steroids, treatments and able to be weaned off O2.  Patient demanded to leave AMA because he did not want to stay in the hospital, he stated he did not even want to come to the hospital initially but his wife made him.  After extensive discussion with patient as to potentially danger to his life by leaving at this time after coming in with hypoxia yesterday requiring O2, patient did not want to stay, removed and he removed his IVs. Discussed with with the patient the necessity to follow-up with his PCP, monitoring his O2 at home at home with his wife's O2 monitoring, and that steroids will be sent to his pharmacy patient left AGAINST MEDICAL ADVICE.   Multifocal COVID pneumonia Hypoxia, secondary to pneumonia Patient's initial O2 was 84% on room air The patient is COVID-positive. CT scan of the abdomen was negative for pulmonary embolism.  There is extensive bibasilar consolidation and additional scattered patchy groundglass opacities. Patient was given treatments, supplemental O2, and Decadron Patient was in the low 90s off O2 when he left AMA    Diabetes mellitus type 2 with hyperglycemia Continue home meds  Hyponatremia Given IV fluids  Acute on chronic kidney disease stage III Metabolic acidosis Serum creatinine is 1.79 with BUN of 37 and a GFR of 43, serum bicarb 19 Baseline GFR is around 50 Given IV fluids
less energetic; minor pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (less energetic) and VACCINATION SITE PAIN (minor pain at the injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included Energy increased and Energy decreased.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced FATIGUE (less energetic) and VACCINATION SITE PAIN (minor pain at the injection site). At the time of the report, FATIGUE (less energetic) and VACCINATION SITE PAIN (minor pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender who on unknown dates were vaccinated with improperly stored doses of VARIVAX (Merck) (lot numbers and expirations dates were reported as "L001324" exp. "13-JAN-2017" and lot # "L004651" exp. "11-FEB-2017") (route and doses were not provided). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
After running 1/2 mile in School PE, my sonwas feeling chest pains(pressure) and had a light cough.  This persisted for several hours through a visit to urgent care & the er.  @ EKG's were performed, 1 showed irregularities, 2nd did not.  Blood was drawn, x-ray was performed with no obvious issues.
At an offsite J&J clinic. She has a history of fainting from needles. About 10-15 minutes after her vaccine, she passed out in her chair losing consciousness. We called 911, moved her to the floor, elevated her feet, and monitored her breathing. She was out for about 1 minute. EMS arrived and evaluated her for about 1h before she walked out on her own.
My left arm cannot swing backwards. Can?t reach to the side. Can?t stretch. It used to be able to reach  my upper back  but now can only reach my butt. Can?t lift.
received the 2nd dose of the Moderna vaccine, 23 days apart from the 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the 2nd dose of the Moderna vaccine, 23 days apart from the 1st dose) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 002A21A) for COVID-19 vaccination.     Concomitant products included VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMIN D 3), ACETYLSALICYLIC ACID (ASPIRIN 81), CALCIUM, DONEPEZIL HYDROCHLORIDE (ARICEPT), LEVOTHYROXINE SODIUM (SYNTHROID), LORATADINE, PREDNISONE, MULTIVITAMINS [VITAMINS NOS], SIMVASTATIN (ZOCOR) and TOPIRAMATE (TOPAMAX) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the 2nd dose of the Moderna vaccine, 23 days apart from the 1st dose). On 09-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the 2nd dose of the Moderna vaccine, 23 days apart from the 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up received on 28Jun2021 contains no new information
Restless legs; blurry vision; headache; nausea; lots of confusion; dizzy; metallic taste in mouth
This case meets criteria for vaccine breakthrough review. SxS include ~2 weeks PTA of low grade fever, chills, myalgia, upper respiratory symptoms.
1/8/22 admit to hospital. acute resp failure due to COVID -19, NSTEMI. Linear left basilar opacities noted.  1/17/22 patient placed on BIPAP. family made him DNR 1/17/22 patient died
Missed the second dose for 52 days now; A spontaneous report was received from a Pharmacist concerning herself, 88 years- old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and missed the second dose for 52 days now.  No patient's medical history was reported. No relevant concomitant medications were reported.  On 11 Jan 2021, prior to the onset of the events, the patient received their first of the two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection.  As of 04 March 2021, the patient reported that she missed the second dose for 52 days now.  No Laboratory investigations were provided. No Treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   At the time of this report, the outcome of the event, missed the second dose for 52 days now was considered resolved.; Reporter's Comments: This report refers to a case of Inappropriate schedule of product administration for mRNA-1273, lot # unknown, with no associated AEs.
Saturday 1:00 am Headache fatigue muscle pain dizzy confusion join pain fever 100.5  Sunday- Monday the same as Saturday  Tuesday add sinus infection and coughing green phlegm from lungs Thursday  add ear pain   Tested positive for Covid  Confusion went away Saturday turned to sinus pain and congestion with headache. Fevers only at night. Muscle joint pain getting better Sunday- Saturday  Fatigue has never let up in two weeks. Headache still for two weeks. Sinus infection.
After off the label use of Rotavirus vaccine #1 on 4/14/08, patient developed acute enteritis for about 7-8 days - seen at ER (Rotavirus vaccine was not ordered by MD)
Initial information received on 07-Sep-2018 regarding an unsolicited valid non-serious case received from other health professional. This case involves a child male patient (age was reported as 2) who was mistakenly vaccinated with a 0.25 ml single expired dose of FLUZONE QUADRIVALENT (batch number: UT5897NA, expiration date: 07-Jun-2018, dose, dose in series, route and site of administration were not reported) on 06-Sep-2018. The patient's concomitant medications, medical history and previous medications was not reported. It was a case of actual medication error due to expired vaccine used. It was not reported whether the patient experienced any adverse reactions following the vaccination. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Woke up on 03/16/2021 and noticed left eye ,the white area was blood shot.  No drainage, no itching, no visual changes from baseline. No swelling noted. She has been using a cold washcloth on eye without any relief. Patient was instructed to contact her eye Dr. that she is going to for treatment of her macular degeneration and discuss this.  PHN also noted that if her eye specialist was not in or clinic not open to contact her local primary eye doctor.  PHN instructed patient to monitor for drainage, swelling, itching, eye pressure,  headache,temperature, vomiting or any changes in vision,  to be seen by MD.  03/22/2021 TC to patient who notes that when she woke up on 03/21/21 her symptoms have resolved.  She was to eye Dr. locally today 03/22/21 but was told she could cancel if s/s resolved.
Narrative:  COVID infection following COVID vaccine series 02/19, Pfizer, dose #1 03/16, Pfizer, dose #2 1/2/2022 COVID swab, result: detected 12/25 pt cc: Myalgias, chills, cough, fever, rhinorrhea exposure: unknown  12/26 COVID swab, result: detected 12/26 SARS-COV-2 Variant Sequencing: pending 12/27 pt admit ED cc: URI sx, dx: Covid-19 LOS: 1 day
Patient was very worried before she even received her dose as she has a serious Latex allergy. She even brought her own epipen and boxes of latex free gloves for staff to use. After waiting 30 minutes, pt waved down a medical assistant who was walking by and informed him she started to taste metal in her mouth and felt a lump in her throat that wasn't there previously. Patient was very calm and alert. I took her vitals which were normal. As time went on and we were reviewing pt's medical history (maybe 5 min), pt said her tongue started to feel like it was swelling and she started to feel very slightly dizzy. I told her we should probably call medical service so they can evaluate her further and see if she needs epi. She agreed. Medical service was called they examined pt, and afterward, decided to schedule her downstairs where they wheeled pt down in a wheelchair. She was able to walk and sit in the wheelchair under her own power. She was assessed and observed. No intervention was required.
Right after administration of Flu shot to left arm, left arm was numb feeling and left hand was tingling.  Wednesday 0900, right arm numb and right hand tingling.  Next day, Thursday around 1200PM both feet had tingling sensation, slight numbness.
received vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (received vaccine while pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 15-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (received vaccine while pregnant). On 15-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (received vaccine while pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.  Caller stated had  first dose in January and the second dose in February.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Updated the dose number to 1st dose; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Pt developed erythematous indurated area below vaccination site approximately 8-10cm diameter lasting about 48 hours.  Tx with anti-histamine and ice.
SEIZURES- FOCAL AWARE /FOCAL MOTOR / SIMPLE PARTIAL  BILATERAL FLANK PAIN FOR APPROXIMATELY A MONTH
my arm is really really sore; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (my arm is really really sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (my arm is really really sore). At the time of the report, PAIN IN EXTREMITY (my arm is really really sore) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   Reporter did not allow further contact
chills, vomiting, nausea, intense muscle aches, fever, dizziness.  started suddenly around 11pm to midnight, lasted through the night.  in am of 4/13,  still felt ill
Within 24 hours of vaccination, onset of severe headache, body aches, fatigue and fever of 102 F lasting approximately 48-72 hours. Injection site became hot, itchy and swollen and redness grew to approximately 4-5 inches across. Used warm compress and ice pack on arm. Took Acetaminophen for fever and pain management. Arm is improving but still swollen, red  and sore on day 4 but other symptoms have subsided.
8 hours after vaccine: chills lasting about 4 hours 11 hours after vaccine: fever up to 101.4°F lasting about 8 hours, followed by mild fever about 100.4°F 18 hours or more Intermittent dizziness when standing during the course of the fever. Intermittent mild nausea during the course of the fever Treatment: bed rest and liquids
Pain at the injection site; Redness at the injection site; Swelling at the injection site; Muscle pain; Tiredness; Headache; Shivering; Fever; Upset stomach; Arm pain; Rash; This case was reported by a consumer and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included multiple allergies (the patient had allergies but could not find out what the active and inactive ingredients for this product).   On 27th January 2023, the patient received the 1st dose of Shingrix. In January 2023, unknown after receiving Shingrix, the patient experienced pain in arm and rash. On 27th January 2023, the patient experienced injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache, shivering, fever and upset stomach. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache, shivering, fever and upset stomach were not recovered/not resolved and the outcome of the pain in arm and rash were unknown.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, muscle pain, tiredness, headache, shivering, fever, upset stomach, pain in arm and rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 29-Jan-2023 Reporter's Comments: This case was self-reported by the patient. The patient experienced pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever and upset stomach was ongoing. The patient also experienced arm pain and rash. The unspecified expiry date of Shingrix was unknown. The patient tried to find out the ingredients that had an allergies but could not find out what the active and inactive ingredients for this product. The symptoms were not treated.  The reporter had gave the permission to contact you.